X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CRDL

Closed

Cardiol Therapeutics Inc Class A

1.32
-0.04 (-2.94%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.36
Day's Range: 1.3 - 1.4
Send
When Written:
 
0.4873
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on developing innovative therapies for heart diseases. The company is headquartered in Oakville, Ontario, Canada, and its Class A shares are listed on the Toronto Stock Exchange (TSX: CRDL).

Cardiol Therapeutics is developing a proprietary platform technology called CardiolRx, which is based on the use of cannabidiol (CBD) for the treatment of heart diseases. The company's lead product candidate is CardiolRx, a pharmaceutically produced CBD formulation that is being developed for the treatment of acute myocarditis, a severe inflammation of the heart muscle.

Cardiol Therapeutics is also exploring the potential of CardiolRx for the treatment of other heart diseases, including heart failure and other forms of myocarditis. The company has a strong intellectual property portfolio, with multiple patents and patent applications covering its technology and product candidates.

Cardiol Therapeutics is led by a team of experienced executives and scientists with a track record of success in drug development and commercialization. The company has partnerships with leading academic institutions and research organizations, and is well-funded to advance its pipeline of product candidates.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X